JP2015528504A - 抗疼痛及び抗嘔気及び／又は抗嘔吐組み合わせ組成物 - Google Patents

抗疼痛及び抗嘔気及び／又は抗嘔吐組み合わせ組成物 Download PDF

Info

Publication number
JP2015528504A
JP2015528504A JP2015532043A JP2015532043A JP2015528504A JP 2015528504 A JP2015528504 A JP 2015528504A JP 2015532043 A JP2015532043 A JP 2015532043A JP 2015532043 A JP2015532043 A JP 2015532043A JP 2015528504 A JP2015528504 A JP 2015528504A
Authority
JP
Japan
Prior art keywords
film
drug delivery
delivery system
active ingredient
pharmaceutically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015532043A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015528504A5 (enExample
Inventor
エリック ダデイ
エリック ダデイ
ゲイリー エル マイヤーズ
ゲイリー エル マイヤーズ
ダニエル バーバー
ダニエル バーバー
アレクサンダー マーク ショベル
アレクサンダー マーク ショベル
Original Assignee
モノソル アールエックス リミテッド ライアビリティ カンパニー
モノソル アールエックス リミテッド ライアビリティ カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by モノソル アールエックス リミテッド ライアビリティ カンパニー, モノソル アールエックス リミテッド ライアビリティ カンパニー filed Critical モノソル アールエックス リミテッド ライアビリティ カンパニー
Publication of JP2015528504A publication Critical patent/JP2015528504A/ja
Publication of JP2015528504A5 publication Critical patent/JP2015528504A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2015532043A 2012-09-12 2013-09-12 抗疼痛及び抗嘔気及び／又は抗嘔吐組み合わせ組成物 Pending JP2015528504A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261700146P 2012-09-12 2012-09-12
US61/700,146 2012-09-12
US13/843,718 2013-03-15
US13/843,718 US20140073678A1 (en) 2012-09-12 2013-03-15 Anti-pain and anti-nausea and/or vomiting combinatorial compositions
PCT/US2013/059460 WO2014043346A2 (en) 2012-09-12 2013-09-12 Anti-pain and anti-nausea and/or vomiting combinatorial compositions

Publications (2)

Publication Number Publication Date
JP2015528504A true JP2015528504A (ja) 2015-09-28
JP2015528504A5 JP2015528504A5 (enExample) 2016-08-18

Family

ID=50233885

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015532043A Pending JP2015528504A (ja) 2012-09-12 2013-09-12 抗疼痛及び抗嘔気及び／又は抗嘔吐組み合わせ組成物

Country Status (6)

Country Link
US (1) US20140073678A1 (enExample)
EP (1) EP2895145A2 (enExample)
JP (1) JP2015528504A (enExample)
AU (1) AU2013315484A1 (enExample)
CA (1) CA2884757A1 (enExample)
WO (1) WO2014043346A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020519669A (ja) * 2017-05-17 2020-07-02 コンフルーエンス ファーマシューティカルズ，エルエルシー ホモタウリンおよびその塩の製剤

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2124556T1 (sl) 2006-10-09 2015-01-30 Charleston Laboratories, Inc. Farmacevtske sestave
EP2240022B1 (en) 2008-01-09 2016-12-28 Charleston Laboratories, Inc. Bilayered tablets comprising oxycodone and promethazine
EP3311667A1 (en) 2009-07-08 2018-04-25 Charleston Laboratories, Inc. Pharmaceutical compositions
US20140275194A1 (en) * 2013-03-15 2014-09-18 Monosol Rx, Llc Films and drug delivery systems for rizatriptan
AU2015280262B2 (en) 2014-06-24 2020-08-13 Taho Pharmaceuticals Ltd. Fast acting orally disintegrating film
RU2017111887A (ru) * 2014-09-09 2018-10-11 Чарлстон Лэбораториз, Инк. Фармацевтические композиции
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
WO2019069123A1 (en) * 2017-10-07 2019-04-11 Zim Laboratories Ltd. METHOD FOR PREPARING A BI OR MULTILAYER FILM, MULTILAYER FILM PRODUCED THEREFROM, AND APPARATUS FOR PRODUCING SUCH MULTILAYER FILMS
DE102017127452A1 (de) * 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag Wasserlösliche Polymerklebschichten
WO2022104234A1 (en) * 2020-11-15 2022-05-19 Castor Trevor P Methods for assaying and measuring the efficacy of anti-nausea compounds

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001039836A1 (en) * 1999-12-01 2001-06-07 Natco Pharma Limited A rapid acting freeze dired oral pharmaceutical composition for treating migraine
JP2008534562A (ja) * 2005-03-28 2008-08-28 オレクソ・アクチエボラゲット 偏頭痛の治療に有用な新しい製薬組成物
JP2010270118A (ja) * 2009-05-19 2010-12-02 Monosol Rx Llc オンダンセトロン膜組成物
WO2011006012A1 (en) * 2009-07-08 2011-01-13 Charleston Laboratories Inc. Pharmaceutical compositions
CN102028672A (zh) * 2010-09-29 2011-04-27 上海现代药物制剂工程研究中心有限公司 微孔海绵状药膜制剂及其制备方法
JP2011518881A (ja) * 2008-04-28 2011-06-30 ゾゲニクス インコーポレーティッド 片頭痛の治療のための製剤
JP2012513955A (ja) * 2008-11-03 2012-06-21 エヌエーエル ファーマスーティカルズ リミテッド 経口投与剤形

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0613925D0 (en) * 2006-07-13 2006-08-23 Unilever Plc Improvements relating to nanodispersions
US8580830B2 (en) * 2006-10-02 2013-11-12 Labtec Gmbh Non-mucoadhesive film dosage forms
ES2699077T3 (es) * 2009-06-12 2019-02-07 Sunovion Pharmaceuticals Inc Apomorfina sublingual

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001039836A1 (en) * 1999-12-01 2001-06-07 Natco Pharma Limited A rapid acting freeze dired oral pharmaceutical composition for treating migraine
JP2008534562A (ja) * 2005-03-28 2008-08-28 オレクソ・アクチエボラゲット 偏頭痛の治療に有用な新しい製薬組成物
JP2011518881A (ja) * 2008-04-28 2011-06-30 ゾゲニクス インコーポレーティッド 片頭痛の治療のための製剤
JP2012513955A (ja) * 2008-11-03 2012-06-21 エヌエーエル ファーマスーティカルズ リミテッド 経口投与剤形
JP2010270118A (ja) * 2009-05-19 2010-12-02 Monosol Rx Llc オンダンセトロン膜組成物
WO2011006012A1 (en) * 2009-07-08 2011-01-13 Charleston Laboratories Inc. Pharmaceutical compositions
CN102028672A (zh) * 2010-09-29 2011-04-27 上海现代药物制剂工程研究中心有限公司 微孔海绵状药膜制剂及其制备方法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020519669A (ja) * 2017-05-17 2020-07-02 コンフルーエンス ファーマシューティカルズ，エルエルシー ホモタウリンおよびその塩の製剤
US12042566B2 (en) 2017-05-17 2024-07-23 Confluence Pharmaceuticals, Llc Formulations of homotaurines and salts thereof

Also Published As

Publication number Publication date
WO2014043346A3 (en) 2014-07-31
CA2884757A1 (en) 2014-03-20
US20140073678A1 (en) 2014-03-13
WO2014043346A2 (en) 2014-03-20
AU2013315484A1 (en) 2015-04-09
EP2895145A2 (en) 2015-07-22

Similar Documents

Publication Publication Date Title
JP2015528504A (ja) 抗疼痛及び抗嘔気及び／又は抗嘔吐組み合わせ組成物
US9855221B2 (en) Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8840919B2 (en) Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
JP6198370B2 (ja) 経口投与剤形
RU2460519C2 (ru) Биоразрушаемый пластырь
JP5717946B2 (ja) ポリビニルアルコール−ポリエチレングリコールグラフト共重合体を含有する泡状ウェハ
JP2009518405A (ja) 活性物質の送達のための局所フィルム組成物
US20090253754A1 (en) Fast dissolving films and coatings for controlled release of flavors, active pharmaceutical ingredients, food substances, and nicotine
CN101668519A (zh) 聚合物基薄膜以及由其制备的药物递送系统
JP2009507854A (ja) 粘着防止剤を組み込む即溶性製剤用の均一なフィルム
CZ20012566A3 (cs) Jednotková dávka a způsob přípravy jednotkové dávky pro slizniční podávání
CN101516331A (zh) 含有抗泡沫调味剂的可食用水溶性膜
JP2010515761A (ja) 高用量フィルム組成物およびその製法
CN103298459A (zh) 用于直接在包装表面上形成药用产品的方法和系统
JP2012512167A (ja) 可食性フィルムの製造方法
JP2009521532A (ja) 活性物質を放出するための、ｐＨ調節されたフィルム
Chauhan et al. A comprehensive review on mucoadhesive drug delivery
CA2906050C (en) Films and drug delivery systems for rizatriptan

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160630

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160630

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170419

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20171113